enVVeno Medical Corp (NVNBW)
2025-06-30 | ||||
|---|---|---|---|---|
| Selling, general and administrative expenses | 4,158 | |||
| Research and development expenses | 2,891 | |||
| Loss from operations | -7,049 | |||
| Unrealized gain (loss) from trading securities | -79 | |||
| Realized gains from sales of trading securities | 239 | |||
| Interest income, net | 195 | |||
| Total other income | 355 | |||
| Net loss | -6,694 | |||
| Basic | 20,352,000 | |||
| Diluted | 20,352,000 | |||
| Net loss per basic common share | -0.33 | |||
| Net loss per diluted common share | -0.33 | |||